Skip to main content
NKTR $36.32 -2.55%
NKTR logo
NKTR · Nektar Therapeutics
Track NKTR — free
$36.32 -0.95 (-2.55%) Play latest call Q3 2026 earnings call transcript
Market Cap
$1.28B
Shares
34.21M
Volume · Nov 16 216.39K Avg daily vol (3M) 1.1M
All webcasts

Earnings call · FY2024 Q4

Nektar Therapeutics (NKTR) Q4 2024 Earnings Call

Concluded Mar 12, 2025
Mar 12, 2025
Period
FY2024 Q4
Runtime
—
Sources
2 artifacts
Revenue · derived Q4 $29.18M +22.1% YoY
Gross margin · derived Q4 72.7% +3.2 pp YoY
Net income · derived Q4 $7.26M
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document